Arcturus Therapeutics Stock (NASDAQ: ARCT) stock price, news, charts, stock research, profile.
Open | $24.10 |
Close | $23.88 |
Volume / Avg. | 414.33K / 608.12K |
Day Range | 23.43 - 24.68 |
52 Wk Range | 17.52 - 45.00 |
Market Cap | $643.13M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 27.34% |
Days to Cover | 5.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arcturus Therapeutics (NASDAQ:ARCT) through any online brokerage.
Other companies in Arcturus Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), 4D Molecular Therapeutics (NASDAQ:FDMT), Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR) and Replimune Group (NASDAQ:REPL).
There is no analysis for Arcturus Therapeutics.
Arcturus Therapeutics has a consensus price target of $51.50.
The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $23.88 last updated Today at July 22, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Arcturus Therapeutics.
Arcturus Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Arcturus Therapeutics.
Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.